학술논문
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study
Document Type
Article
Author
Hui, Rina ; Özgüroğlu, Mustafa ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Yokoi, Takashi ; Chiappori, Alberto ; Lee, Ki Hyeong ; de Wit, Maike ; Cho, Byoung Chul ; Gray, Jhanelle E ; Rydén, Anna ; Viviers, Louis ; Poole, Lynne ; Zhang, Yiduo ; Dennis, Phillip A ; Antonia, Scott J
Source
In The Lancet Oncology December 2019 20(12):1670-1680
Subject
Language
ISSN
1470-2045
Abstract
Funding AstraZeneca.